LASSO NTCP predictors for the incidence of xerostomia in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma

被引:28
|
作者
Lee, Tsair-Fwu [1 ]
Liou, Ming-Hsiang [2 ,3 ]
Huang, Yu-Jie [4 ,5 ]
Chao, Pei-Ju [1 ,4 ,5 ]
Ting, Hui-Min [1 ,4 ,5 ]
Lee, Hsiao-Yi [2 ]
Fang, Fu-Min [4 ,5 ]
机构
[1] Natl Kaohsiung Univ Appl Sci, Med Phys & Informat Lab Elect Engn, Kaohsiung 807, Taiwan
[2] Natl Kaohsiung Univ Appl Sci, Dept Elect Engn, Kaohsiung 807, Taiwan
[3] Kaohsiung Yuans Gen Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan
[4] Kaohsiung Chang Gung Mem Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan
[5] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan
来源
SCIENTIFIC REPORTS | 2014年 / 4卷
关键词
QUALITY-OF-LIFE; INTENSITY-MODULATED RADIOTHERAPY; 3-DIMENSIONAL CONFORMAL RADIOTHERAPY; COMPLICATION PROBABILITY; STICKY SALIVA; DOSE-VOLUME; MULTIVARIATE-ANALYSIS; RATED XEROSTOMIA; GLAND FUNCTION; CANCER;
D O I
10.1038/srep06217
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
To predict the incidence of moderate-to-severe patient-reported xerostomia among head and neck squamous cell carcinoma (HNSCC) and nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiotherapy (IMRT). Multivariable normal tissue complication probability (NTCP) models were developed by using quality of life questionnaire datasets from 152 patients with HNSCC and 84 patients with NPC. The primary endpoint was defined as moderate-to-severe xerostomia after IMRT. The numbers of predictive factors for a multivariable logistic regression model were determined using the least absolute shrinkage and selection operator (LASSO) with bootstrapping technique. Four predictive models were achieved by LASSO with the smallest number of factors while preserving predictive value with higher AUC performance. For all models, the dosimetric factors for the mean dose given to the contralateral and ipsilateral parotid gland were selected as the most significant predictors. Followed by the different clinical and socio-economic factors being selected, namely age, financial status, T stage, and education for different models were chosen. The predicted incidence of xerostomia for HNSCC and NPC patients can be improved by using multivariable logistic regression models with LASSO technique. The predictive model developed in HNSCC cannot be generalized to NPC cohort treated with IMRT without validation and vice versa.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] LASSO NTCP predictors for the incidence of xerostomia in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma
    Tsair-Fwu Lee
    Ming-Hsiang Liou
    Yu-Jie Huang
    Pei-Ju Chao
    Hui-Min Ting
    Hsiao-Yi Lee
    Fu-Min Fang
    [J]. Scientific Reports, 4
  • [2] Dosimetric predictors of aspiration in patients with squamous cell carcinoma of the head and neck
    Schaner, P. E.
    Caudell, J. J.
    Spencer, S. A.
    Meredith, R. F.
    Desmond, R. A.
    Bonner, J. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S157 - S158
  • [3] Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma
    Thomas, GR
    Nadiminti, H
    Regalado, J
    [J]. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2005, 86 (06) : 347 - 363
  • [4] Simple predictors of survival in head and neck squamous cell carcinoma
    Medow, MA
    Weed, HG
    Schuller, DE
    [J]. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2002, 128 (11) : 1282 - 1286
  • [5] Biological predictors of radiosensitivity in head and neck squamous cell carcinoma
    Mathias Fiedler
    Florian Weber
    Matthias G. Hautmann
    Frank Haubner
    Torsten E. Reichert
    Christoph Klingelhöffer
    Stephan Schreml
    Johannes K. Meier
    Arndt Hartmann
    Tobias Ettl
    [J]. Clinical Oral Investigations, 2018, 22 : 189 - 200
  • [6] Biological predictors of radiosensitivity in head and neck squamous cell carcinoma
    Fiedler, Mathias
    Weber, Florian
    Hautmann, Matthias G.
    Haubner, Frank
    Reichert, Torsten E.
    Klingelhoeffer, Christoph
    Schreml, Stephan
    Meier, Johannes K.
    Hartmann, Arndt
    Ettl, Tobias
    [J]. CLINICAL ORAL INVESTIGATIONS, 2018, 22 (01) : 189 - 200
  • [7] High incidence of head and neck squamous cell carcinoma in patients with Fanconi Anemia
    Kutler, DI
    Auerbach, AD
    Satagopan, J
    Giampietro, PF
    Batish, SD
    Huvos, AG
    Goberdhan, A
    Shah, JP
    Singh, B
    [J]. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2003, 129 (01) : 106 - 112
  • [8] THE INCIDENCE OF HYPERCALCEMIA IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    DORMAN, EB
    YANG, H
    VAUGHAN, CW
    HONG, WK
    STRONG, MS
    [J]. HEAD & NECK SURGERY, 1984, 7 (02): : 95 - 98
  • [9] Chronic Periodontitis and the Incidence of Head and Neck Squamous Cell Carcinoma
    Tezal, Mine
    Sullivan, Maureen A.
    Hyland, Andrew
    Marshall, James R.
    Stoler, Daniel
    Reid, Mary E.
    Loree, Thom R.
    Rigual, Nestor R.
    Merzianu, Mihai
    Hauck, Linda
    Lillis, Cheryl
    Wactawski-Wende, Jean
    Scannapieco, Frank A.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (09) : 2406 - 2412
  • [10] Phase II trial of sorafenib in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or nasopharyngeal carcinoma
    Elser, Christine
    Siu, Lillian L.
    Winquist, Eric
    Agulnik, Mark
    Pond, Gregory R.
    Chin, Soo F.
    Francis, Peggy
    Cheiken, Robin
    Elting, James
    McNabola, Angela
    Wilkie, Dean
    Petrenciuc, Oana
    Chen, Eric X.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (24) : 3766 - 3773